US3121076A
(en)
|
|
1964-02-11 |
|
Benzodiazepinones and processes |
US1873732A
(en)
|
1928-12-28 |
1932-08-23 |
Abbott Lab |
Bactericide applicable to acid-fast bacteria
|
US3019843A
(en)
|
1956-07-27 |
1962-02-06 |
Powell Dawson |
Fire inhibitor and extinguisher
|
US2942572A
(en)
|
1958-06-17 |
1960-06-28 |
Pall Corp |
Magnetic pressure indicator
|
US3136815A
(en)
|
1959-12-10 |
1964-06-09 |
Hoffmann La Roche |
Amino substituted benzophenone oximes and derivatives thereof
|
US3371085A
(en)
|
1959-12-10 |
1968-02-27 |
Hoffmann La Roche |
5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
|
US3116203A
(en)
|
1962-03-14 |
1963-12-31 |
Hoffmann La Roche |
Oleaginous systems
|
NL298071A
(es)
|
1963-06-04 |
|
|
|
CH449645A
(de)
|
1963-07-09 |
1968-01-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Aminosäuren
|
CH427803A
(de)
|
1963-12-06 |
1967-01-15 |
Geigy Ag J R |
Verfahren zur Herstellung eines neuen Isoxazolderivates
|
NL129434C
(es)
|
1966-03-12 |
|
|
|
BE759838A
(fr)
|
1969-12-04 |
1971-06-03 |
Wellcome Found |
Cetones a activite biologique
|
US3885046A
(en)
|
1969-12-04 |
1975-05-20 |
Burroughs Wellcome Co |
Meta chloro or fluoro substituted alpha-T-butylaminopropionphenones in the treatment of depression
|
FR2077918B1
(es)
|
1970-02-24 |
1973-04-06 |
Berthier Laboratoires |
|
US3821249A
(en)
|
1970-03-13 |
1974-06-28 |
En Nom Collectif Science Union |
Dibenzothiazefin derivatives
|
US3758528A
(en)
|
1970-03-13 |
1973-09-11 |
Science Union & Cie |
Tricyclic compounds
|
US3819631A
(en)
|
1970-12-15 |
1974-06-25 |
May & Baker Ltd |
Azapurinones
|
OA04285A
(fr)
|
1972-01-07 |
1979-12-31 |
Rhone Poulenc Sa |
Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
|
USRE31617E
(en)
|
1972-02-04 |
1984-06-26 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
US3932407A
(en)
|
1973-11-19 |
1976-01-13 |
Bristol-Myers Company |
Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
|
US4036840A
(en)
|
1972-06-07 |
1977-07-19 |
Icn Pharmaceuticals |
2-Substituted-s-triazolo[1,5a]pyrimidines
|
GB1457873A
(en)
|
1973-01-04 |
1976-12-08 |
Allen & Hanburys Ltd |
Imidazotriazines
|
GB1422263A
(en)
|
1973-01-30 |
1976-01-21 |
Ferrosan As |
4-phenyl-piperidine compounds
|
US4051236A
(en)
|
1973-02-15 |
1977-09-27 |
E. R. Squibb & Sons, Inc. |
Inhibition of blood platelet aggregation
|
US4314081A
(en)
|
1974-01-10 |
1982-02-02 |
Eli Lilly And Company |
Arloxyphenylpropylamines
|
US4280957A
(en)
|
1974-09-11 |
1981-07-28 |
Hoffmann-La Roche Inc. |
Imidazodiazepines and processes therefor
|
AR208414A1
(es)
|
1974-11-07 |
1976-12-27 |
Rhone Poulenc Ind |
Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
|
US4093617A
(en)
|
1974-11-12 |
1978-06-06 |
Icn Pharmaceuticals, Inc. |
3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
US3960927A
(en)
|
1975-03-18 |
1976-06-01 |
Richardson-Merrell Inc. |
Olefinic derivatives of amino acids
|
NL7503310A
(nl)
|
1975-03-20 |
1976-09-22 |
Philips Nv |
Verbindingen met antidepressieve werking.
|
NL189199C
(nl)
|
1975-04-05 |
1993-02-01 |
Akzo Nv |
Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
|
FR2319338A1
(fr)
|
1975-08-01 |
1977-02-25 |
Synthelabo |
Nouveaux derives de a- phenyl benzylideniques des acides amines, leur preparation et les medicaments qui en contiennent
|
GB1526331A
(en)
|
1976-01-14 |
1978-09-27 |
Kefalas As |
Phthalanes
|
YU96177A
(en)
|
1976-04-24 |
1982-08-31 |
Wuelfing Johann A |
Process for obtaining adenine derivatives
|
US4107307A
(en)
|
1977-02-03 |
1978-08-15 |
American Cyanamid Company |
Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
|
USRE30511E
(en)
|
1977-02-03 |
1981-02-10 |
American Cyanamid Company |
Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
|
CA1095906A
(en)
|
1977-02-14 |
1981-02-17 |
Davis L. Temple, Jr. |
Heterocyclopyrimidines, compositions and therapeutic process
|
US4404380A
(en)
|
1977-02-14 |
1983-09-13 |
Mead Johnson & Company |
Triazolopyrimidines
|
US4107309A
(en)
|
1977-05-23 |
1978-08-15 |
American Cyanamid Company |
Substituted imidazo[1,2-d]-as-triazines
|
US4096257A
(en)
|
1977-05-23 |
1978-06-20 |
American Cyanamid Company |
Substituted imidazo [1,2-d]-as-triazines
|
IN148482B
(es)
|
1977-06-03 |
1981-03-07 |
Pfizer |
|
DK270278A
(da)
|
1977-06-20 |
1978-12-21 |
Krogsgaard Larsen P |
Cycliske aminosyrer
|
US4370328A
(en)
|
1977-11-03 |
1983-01-25 |
Pfizer Inc. |
Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
|
CA1086735A
(en)
|
1977-11-03 |
1980-09-30 |
John C. Danilewicz |
Piperidino-quinazolines
|
IL56369A
(en)
|
1978-01-20 |
1984-05-31 |
Erba Farmitalia |
Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
|
US4146718A
(en)
|
1978-04-10 |
1979-03-27 |
Bristol-Myers Company |
Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
|
US4366156A
(en)
|
1979-03-05 |
1982-12-28 |
Mead Johnson & Company |
Antiallergic methods using diazaheterocyclopurines
|
CA1143728A
(en)
|
1979-10-04 |
1983-03-29 |
Max Gerecke |
Imidazodiazepine derivatives
|
US4536518A
(en)
|
1979-11-01 |
1985-08-20 |
Pfizer Inc. |
Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
|
JPS5668695A
(en)
|
1979-11-10 |
1981-06-09 |
Sankyo Co Ltd |
Enzyme inhibitor griseolic acid and its preparation
|
US4642345A
(en)
|
1980-08-14 |
1987-02-10 |
Mead Johnson & Company |
6,7-dihydro-3H-imidazo[1,2-a]-purine-9(4H)-ones
|
US4301176A
(en)
|
1980-08-18 |
1981-11-17 |
Warner-Lambert Company |
Method of administering calcium valproate
|
US4361583A
(en)
|
1980-08-19 |
1982-11-30 |
Synthelabo |
Analgesic agent
|
FR2492258A1
(fr)
|
1980-10-17 |
1982-04-23 |
Pharmindustrie |
Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
|
FR2492382A1
(fr)
|
1980-10-22 |
1982-04-23 |
Synthelabo |
Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
|
US4489078A
(en)
|
1980-11-24 |
1984-12-18 |
Mead Johnson & Company |
Diazaheterocyclopurines used as anti-broncho spasmatics and vasodilators
|
US4338317A
(en)
|
1981-03-16 |
1982-07-06 |
Mead Johnson & Company |
Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
|
US4383999A
(en)
|
1981-05-26 |
1983-05-17 |
Smithkline Beckman Corporation |
Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
|
FR2508035A1
(fr)
|
1981-06-23 |
1982-12-24 |
Fabre Sa Pierre |
Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
|
LU83729A1
(fr)
|
1981-11-04 |
1983-09-01 |
Galephar |
Sels d'acide valproique,leur preparation et leur utilisation
|
CH655110A5
(de)
|
1982-09-03 |
1986-03-27 |
Otsuka Pharma Co Ltd |
Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
|
US4663320A
(en)
|
1983-02-16 |
1987-05-05 |
Syntex (U.S.A.) Inc. |
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
US4626538A
(en)
|
1983-06-23 |
1986-12-02 |
American Cyanamid Company |
[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
|
US4900836A
(en)
|
1983-06-23 |
1990-02-13 |
American Cyanamid Company |
(3-amino-1H-pyrazol-4-yl) (aryl)methanones
|
US4521422A
(en)
|
1983-06-23 |
1985-06-04 |
American Cyanamid Company |
Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
|
US4513006A
(en)
|
1983-09-26 |
1985-04-23 |
Mcneil Lab., Inc. |
Anticonvulsant sulfamate derivatives
|
US4761501A
(en)
|
1983-10-26 |
1988-08-02 |
American Home Products Corporation |
Substituted phenylacetamides
|
US4593029A
(en)
|
1984-02-15 |
1986-06-03 |
Syntex (U.S.A.) Inc. |
Novel ω-(N-imidazolyl)alkyl ethers of 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones
|
GB8425872D0
(en)
|
1984-10-12 |
1984-11-21 |
Ciba Geigy Ag |
Chemical compounds
|
US4855290A
(en)
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
DK288385D0
(da)
|
1985-06-26 |
1985-06-26 |
Novo Industri As |
Aminosyrederivater
|
ES2031821T3
(es)
|
1985-10-17 |
1993-01-01 |
Smith Kline & French Laboratories Limited |
Procedimiento para preparar derivados de 4(4-oxo-1,4-dihidropiridin-1-il)fenilo.
|
US4670434A
(en)
|
1985-11-14 |
1987-06-02 |
Syntex (U.S.A.) Inc. |
(2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
|
US4775674A
(en)
|
1986-05-23 |
1988-10-04 |
Bristol-Myers Company |
Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
|
FR2600650B1
(fr)
|
1986-06-27 |
1988-09-09 |
Synthelabo |
Procede de preparation d'imidazopyridines et composes intermediaires
|
GB8615785D0
(en)
|
1986-06-27 |
1986-08-06 |
Beecham Group Plc |
Compounds
|
EP0261763B1
(en)
|
1986-06-27 |
1994-02-09 |
Beecham Group Plc |
Novel bridged bicyclic N-heterocycles
|
US4701459A
(en)
|
1986-07-08 |
1987-10-20 |
Bristol-Myers Company |
7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
|
US4709094A
(en)
|
1986-07-10 |
1987-11-24 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Sigma brain receptor ligands and their use
|
US5478863A
(en)
|
1986-07-10 |
1995-12-26 |
State Of Oregon, Oregon Health Sciences University Of Oregon |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
US5093525A
(en)
|
1986-07-10 |
1992-03-03 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
|
US5312840A
(en)
|
1986-07-10 |
1994-05-17 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
US4761416A
(en)
|
1986-07-25 |
1988-08-02 |
Syntex (U.S.A.) Inc. |
N-N-disubstituted-ω-[2-amino-3-(carbonylmethyl)-3, 4-dihydroquinazolinyl]oxyalkylamides and related compounds
|
US4739056A
(en)
|
1986-11-26 |
1988-04-19 |
Syntex (U.S.A.) Inc. |
N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl)oxy-alkylamides and related compounds
|
US4786648A
(en)
|
1986-12-08 |
1988-11-22 |
Warner-Lambert Company |
O-substituted tetrahydropyridine oxime cholinergic agents
|
US4710508A
(en)
|
1986-12-08 |
1987-12-01 |
Warner-Lambert Company |
O-substituted tetrahydropyridine oxime cholinergic agents
|
US4766118A
(en)
|
1986-12-22 |
1988-08-23 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical use
|
US4721784A
(en)
|
1986-12-22 |
1988-01-26 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl-2,3,4,5-tetrahydropyridazin-3-ones
|
US5081242A
(en)
|
1986-12-22 |
1992-01-14 |
Ortho Pharmaceutical Corporation |
6-benzoxazinyl- and 6-benzothiazinyl 2,3,4,5-tetrahydropyridazin-3-ones
|
US4956388A
(en)
|
1986-12-22 |
1990-09-11 |
Eli Lilly And Company |
3-aryloxy-3-substituted propanamines
|
US4992457A
(en)
|
1987-03-18 |
1991-02-12 |
Schulman Jerome M |
Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
|
US4929734A
(en)
|
1987-03-31 |
1990-05-29 |
Warner-Lambert Company |
Tetrahydropyridine oxime compounds
|
ATE133415T1
(de)
|
1987-04-15 |
1996-02-15 |
Beecham Group Plc |
Am brückenkopf substituierte azabicyclenderivate
|
GB8714789D0
(en)
|
1987-06-24 |
1987-07-29 |
Lundbeck & Co As H |
Heterocyclic compounds
|
US4981858A
(en)
|
1987-08-13 |
1991-01-01 |
State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research |
Optical isomers
|
USRE35517E
(en)
|
1987-08-25 |
1997-05-20 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
US5232917A
(en)
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
ATE122353T1
(de)
|
1987-10-05 |
1995-05-15 |
Yamanouchi Pharma Co Ltd |
Heterozyklische spiroverbindungen und ihre herstellung.
|
US5412096A
(en)
|
1987-10-05 |
1995-05-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Hydrochloride salts of heterocyclic spiro compounds
|
IL88156A
(en)
|
1987-11-13 |
1997-02-18 |
Novo Nordisk As |
Azacyclic compounds their preparation and pharmaceutical compositions containing them
|
EP0322182A3
(en)
|
1987-12-22 |
1992-01-02 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
US4831031A
(en)
|
1988-01-22 |
1989-05-16 |
Pfizer Inc. |
Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
|
US5091431A
(en)
|
1988-02-08 |
1992-02-25 |
Schering Corporation |
Phosphodiesterase inhibitors
|
DK177889A
(da)
|
1988-04-15 |
1989-10-16 |
Beecham Group Plc |
Hidtil ukendte forbindelser
|
US4957916A
(en)
|
1988-08-05 |
1990-09-18 |
Janssen Pharmaceutica N.V. |
Antipsychotic 3-piperazinylbenzazole derivatives
|
US4861891A
(en)
|
1988-08-31 |
1989-08-29 |
Pfizer Inc. |
Antidepressant N-substituted nicotinamide compounds
|
CA2000041A1
(en)
|
1988-10-13 |
1990-04-13 |
Barry S. Orlek |
Compounds
|
DE8817121U1
(es)
|
1988-11-22 |
1993-02-04 |
Boehringer Ingelheim Kg, 6507 Ingelheim, De |
|
US5286864A
(en)
|
1988-11-22 |
1994-02-15 |
Boehringer Ingelheim Kg |
Quinuclidines, their use as medicaments and processes for their preparation
|
US5043345A
(en)
|
1989-02-22 |
1991-08-27 |
Novo Nordisk A/S |
Piperidine compounds and their preparation and use
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
US4971972A
(en)
|
1989-03-23 |
1990-11-20 |
Schering Corporation |
Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
|
US5278170A
(en)
|
1989-04-13 |
1994-01-11 |
Beecham Group P.L.C. |
Azabicylo oxime compounds
|
ATE269330T1
(de)
|
1989-04-13 |
2004-07-15 |
Beecham Group Plc |
Chemische verbindungen
|
US4956368A
(en)
|
1989-07-24 |
1990-09-11 |
Bristol-Myers Company |
Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
|
US5109002A
(en)
|
1989-09-08 |
1992-04-28 |
Du Pont Merck Pharmaceutical Company |
Antipsychotic 1-cycloalkylpiperidines
|
ATE136031T1
(de)
|
1989-10-07 |
1996-04-15 |
Beecham Group Plc |
Azabizyklische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
CA2029497C
(en)
|
1989-11-08 |
2002-06-04 |
Kunihiro Ninomiya (Deceased) |
4-acylaminopyridine derivative
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
US5010086A
(en)
|
1990-02-28 |
1991-04-23 |
Sterling Drug Inc. |
Imidazopyridines, compositions and use
|
US5149817A
(en)
|
1990-03-05 |
1992-09-22 |
Shionogi & Co., Ltd. |
Teirahydropyridine derivatives
|
GB9005737D0
(en)
|
1990-03-14 |
1990-05-09 |
Beecham Group Plc |
Novel compounds
|
US5169855A
(en)
|
1990-03-28 |
1992-12-08 |
Du Pont Merck Pharmaceutical Company |
Piperidine ether derivatives as psychotropic drugs or plant fungicides
|
US5407938A
(en)
|
1990-04-10 |
1995-04-18 |
Israel Institute For Biological Research |
Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
|
US5852029A
(en)
|
1990-04-10 |
1998-12-22 |
Israel Institute For Biological Research |
Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
|
US5534520A
(en)
|
1990-04-10 |
1996-07-09 |
Fisher; Abraham |
Spiro compounds containing five-membered rings
|
US5116995A
(en)
|
1990-05-25 |
1992-05-26 |
Taisho Pharmaceutical Co., Ltd. |
Carbazole compounds
|
EP0532642A1
(en)
|
1990-05-25 |
1993-03-24 |
STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
US5612211A
(en)
|
1990-06-08 |
1997-03-18 |
New York University |
Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
|
US5250534A
(en)
|
1990-06-20 |
1993-10-05 |
Pfizer Inc. |
Pyrazolopyrimidinone antianginal agents
|
US5095015A
(en)
|
1990-07-24 |
1992-03-10 |
Neurogen Corporation |
Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands
|
JP2935541B2
(ja)
|
1990-06-28 |
1999-08-16 |
サントリー株式会社 |
縮合複素環化合物
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
US5376668A
(en)
|
1990-08-21 |
1994-12-27 |
Novo Nordisk A/S |
Heterocyclic compounds
|
DK198590D0
(da)
|
1990-08-21 |
1990-08-21 |
Novo Nordisk As |
Heterocykliske forbindelser, deres fremstilling og anvendelse
|
US5527813A
(en)
|
1990-08-21 |
1996-06-18 |
Novo Nordisk A/S |
Heterocyclic compounds and their preparation and use
|
IE912974A1
(en)
|
1990-08-24 |
1992-02-26 |
Beecham Group Plc |
Novel compounds
|
CA2050264A1
(en)
|
1990-08-30 |
1992-03-01 |
Raymond Baker |
Substituted pyrazine and its salts, compositions containing them and their use in medicine
|
GB9019095D0
(en)
|
1990-09-01 |
1990-10-17 |
Beecham Group Plc |
Novel compounds
|
US5185446A
(en)
|
1990-09-04 |
1993-02-09 |
Neurogen Corporation |
Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands
|
AU652968B2
(en)
|
1990-10-09 |
1994-09-15 |
Neurogen Corporation |
Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
|
WO1992006959A1
(en)
|
1990-10-12 |
1992-04-30 |
Beecham Group Plc |
1,2,5,6-tetrahydropyridine oxime derivatives
|
EP0481262B1
(en)
|
1990-10-15 |
1995-02-15 |
Societe Des Produits Nestle S.A. |
Treatment of black tea
|
US5139802A
(en)
|
1990-10-15 |
1992-08-18 |
Nestec S.A. |
Oxidation of tea
|
US5091242A
(en)
|
1990-10-30 |
1992-02-25 |
The Research Foundation Of State Univ. Of N.Y. |
Carbon fiber composites having improved fatigue resistance
|
US5744602A
(en)
|
1990-10-31 |
1998-04-28 |
Neurogen Corporation |
Certain imidazoquinoxalines; a new class of GABA brain receptor ligands
|
US6268496B1
(en)
|
1990-10-31 |
2001-07-31 |
Neurogen Corporation |
Certain imidazoquinoxalines: a new class of GABA brain receptor ligands
|
US5130430A
(en)
|
1990-10-31 |
1992-07-14 |
Neurogen Corporation |
2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
|
US5116837A
(en)
|
1990-12-21 |
1992-05-26 |
Ortho Pharmaceutical Corporation |
2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
|
US5162341A
(en)
|
1991-02-22 |
1992-11-10 |
Du Pont Merck Pharmaceutical Company |
Use of sigma receptor antagonists for treatment of amphetamine abuse
|
US5093333A
(en)
|
1991-04-29 |
1992-03-03 |
American Home Products Corporation |
N-substituted-2-aminoquinolines useful for treating hypofunction of the cholinergic system
|
US5137895A
(en)
|
1991-04-29 |
1992-08-11 |
A. H. Robins Company, Incorporated |
3-[N-aroyl(or thioaroyl)aminomethyl]-3-quinuclidinols
|
US5124460A
(en)
|
1991-05-06 |
1992-06-23 |
Merck Sharp & Dohme Ltd. |
Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes
|
DE69226187T2
(de)
|
1991-05-15 |
1998-10-22 |
Yamanouchi Pharma Co Ltd |
(-)-(s)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro(4,5)decan l-tartrat
|
NZ243065A
(en)
|
1991-06-13 |
1995-07-26 |
Lundbeck & Co As H |
Piperidine derivatives and pharmaceutical compositions
|
US5641791A
(en)
|
1991-08-13 |
1997-06-24 |
Novo Nordisk A.S |
Heterocyclic compounds and their preparation and use
|
US5182290A
(en)
|
1991-08-27 |
1993-01-26 |
Neurogen Corporation |
Certain oxazoloquinolinones; a new class of GABA brain receptor ligands
|
US5182386A
(en)
|
1991-08-27 |
1993-01-26 |
Neurogen Corporation |
Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
|
US5369108A
(en)
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
US5585490A
(en)
|
1991-10-08 |
1996-12-17 |
Neurogen Corporation |
Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands
|
US5212310A
(en)
|
1991-12-19 |
1993-05-18 |
Neurogen Corporation |
Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
|
US5243049A
(en)
|
1992-01-22 |
1993-09-07 |
Neurogen Corporation |
Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
|
MX9300875A
(es)
|
1992-02-20 |
1993-08-31 |
Smithkline Beecham Plc |
Procedimiento para la preparacion de compuestos azabiciclicos.
|
US6225115B1
(en)
|
1992-03-04 |
2001-05-01 |
Synaptic Pharmaceutical Corporation |
DNA encoding taurine and GABA transporters and uses thereof
|
US5298657A
(en)
|
1992-03-20 |
1994-03-29 |
Cambridge Neuroscience Inc. |
Preparation of substituted guanidines
|
US5294612A
(en)
|
1992-03-30 |
1994-03-15 |
Sterling Winthrop Inc. |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
|
AU4117493A
(en)
|
1992-04-08 |
1994-11-21 |
Neurogen Corporation |
Certain aryl fused pyrrolopyrimidines; a new class of gaba brain receptor ligands
|
US5367077A
(en)
|
1992-04-08 |
1994-11-22 |
Neurogen Corporation |
Certain cycloalkyl and azacycloalkyl pyrrolopyridines; a new class of gaba rain receptor ligands
|
US5266698A
(en)
|
1992-04-30 |
1993-11-30 |
Neurogen Corporation |
Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
|
SE9201478D0
(sv)
|
1992-05-11 |
1992-05-11 |
Kabi Pharmacia Ab |
Heteroaromatic quinuclidinenes, their use and preparation
|
ES2060547B1
(es)
|
1992-06-04 |
1995-06-16 |
Ferrer Int |
Mejoras en el objeto de la patente de invencion n/ 9201158 que se refiere a "procedimiento de obtencion de nuevos derivados de la 4-bencilpiperidina".
|
GB9212673D0
(en)
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
GB9212693D0
(en)
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
JP2683783B2
(ja)
|
1992-07-10 |
1997-12-03 |
雪印乳業株式会社 |
シェーグレン症候群治療剤
|
US5928947A
(en)
|
1992-07-27 |
1999-07-27 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
US5306819A
(en)
|
1992-08-27 |
1994-04-26 |
Neurogen Corporation |
Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
|
ZA937382B
(en)
|
1992-10-06 |
1994-04-29 |
Warner Lambert Co |
Novel composition for peroral therapy of cognitionimpairment and a process therefor
|
GB9222253D0
(en)
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
US5286860A
(en)
|
1992-11-12 |
1994-02-15 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
US5668283A
(en)
|
1992-11-12 |
1997-09-16 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
US5622977A
(en)
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
US5610299A
(en)
|
1993-01-06 |
1997-03-11 |
Neurogen Corporation |
Certain aryl substituted imidazopyrazinones; a new class of GABA brain receptor ligands
|
DE59401358D1
(de)
|
1993-01-23 |
1997-02-06 |
Hoechst Ag |
2,3-Difluor-6-nitrobenzonitril und 2-Chlor-5,6-difluorbenzonitril, Verfahren zu deren Herstellung und ihre Verwendung zur Herstellung von 2,3,6-Trifluorbenzoesäure
|
US5362860A
(en)
|
1993-02-01 |
1994-11-08 |
Warner-Lambert Company |
Neutral stabilization complex for CI-979 HCl, a cognition activator
|
US5424301A
(en)
|
1993-02-01 |
1995-06-13 |
Warner-Lambert Company |
Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
|
US6013799A
(en)
|
1993-03-03 |
2000-01-11 |
Neurogen Corporation |
Certain cycloalkyl imidazopyrimides, a new class of gaba brain receptor ligands
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
DK0690850T3
(da)
|
1993-03-26 |
1998-02-09 |
Schering Corp |
2-Substituerede morpholin- og thiomorpholinderivater som GABAB-antagonister
|
US5750702A
(en)
|
1993-10-27 |
1998-05-12 |
Neurogen Corporation |
Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
|
ES2204920T3
(es)
|
1993-05-27 |
2004-05-01 |
Cenes Limited |
Guanidinas substituidas terapeuticas.
|
GB9301192D0
(en)
|
1993-06-09 |
1993-06-09 |
Trott Francis W |
Flower shaped mechanised table
|
WO1995000131A1
(en)
|
1993-06-23 |
1995-01-05 |
Cambridge Neuroscience, Incorporated |
Sigma receptor ligands and the use thereof
|
CA2165192C
(en)
|
1993-07-02 |
2001-04-24 |
Hermann Amschler |
Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
|
ES2074946B1
(es)
|
1993-07-19 |
1996-06-16 |
Ferrer Int |
Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
US5484944A
(en)
|
1993-10-27 |
1996-01-16 |
Neurogen Corporation |
Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
|
WO1995014681A1
(en)
|
1993-11-26 |
1995-06-01 |
Pfizer Inc. |
Isoxazoline compounds as antiinflammatory agents
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
ATE187447T1
(de)
|
1993-11-26 |
1999-12-15 |
Pfizer |
3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel
|
US5500420A
(en)
|
1993-12-20 |
1996-03-19 |
Cornell Research Foundation, Inc. |
Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
|
GB9326173D0
(en)
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
GB9326699D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
JP3806144B2
(ja)
|
1993-12-22 |
2006-08-09 |
セルテック セラピューティックス リミテッド |
三置換フェニル誘導体、その調製方法とホスホジエステラーゼ(iv型)阻害剤としてのその使用
|
US5668174A
(en)
|
1993-12-29 |
1997-09-16 |
Kowa Tekuno Sachi Co., Ltd. |
Method of treating hyperparathyroidism
|
US7060450B1
(en)
|
1993-12-30 |
2006-06-13 |
President And Fellows Of Harvard College |
Screening assays for agonists and antagonists of the hedgehog signaling pathway
|
GB9514465D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Chemical compounds
|
GB9401090D0
(en)
|
1994-01-21 |
1994-03-16 |
Glaxo Lab Sa |
Chemical compounds
|
IL112638A
(en)
|
1994-02-14 |
2003-10-31 |
Cocensys Inc |
3alpha-HYDROXYLATED PREGNANE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
|
US5939545A
(en)
|
1994-02-14 |
1999-08-17 |
Cocensys, Inc. |
Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
|
CA2185670A1
(en)
|
1994-03-14 |
1995-09-21 |
Palle Jakobsen |
Heterocyclic compounds, their preparation and use
|
US5696148A
(en)
|
1994-03-14 |
1997-12-09 |
Novo Nordisk A/S |
Indole compounds and their use in treating diseases of the central nervous system
|
US5783575A
(en)
|
1994-03-14 |
1998-07-21 |
Novo Nordisk A/S |
Antagonists, their preparation and use
|
US5637617A
(en)
|
1994-04-01 |
1997-06-10 |
The Regents Of The University Of California |
Methods for use of GABAa receptor GABAergic compounds
|
GB9409718D0
(en)
|
1994-05-14 |
1994-07-06 |
Smithkline Beecham Plc |
Novel compounds
|
GB9409705D0
(en)
|
1994-05-14 |
1994-07-06 |
Smithkline Beecham Plc |
Novel compounds
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412672D0
(en)
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
JP2852608B2
(ja)
|
1994-06-27 |
1999-02-03 |
雪印乳業株式会社 |
口腔乾燥症治療剤
|
US5661184A
(en)
|
1994-08-12 |
1997-08-26 |
Eli Lilly And Company |
Psychiatric agents
|
WO1996006098A1
(en)
|
1994-08-24 |
1996-02-29 |
Astra Aktiebolag |
Spiro-azabicyclic compounds useful in therapy
|
HUT76980A
(hu)
|
1994-08-29 |
1998-01-28 |
Yamanouchi Pharmaceutical Co. Ltd. |
Új naftiridinszármazékok és ezeket a vegyületeket tartalmazó gyógyászati készítmények
|
WO1996010570A1
(en)
|
1994-09-30 |
1996-04-11 |
Pfizer Inc. |
NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
|
US5554645A
(en)
|
1994-10-03 |
1996-09-10 |
Mars, Incorporated |
Antineoplastic cocoa extracts and methods for making and using the same
|
DE4436509A1
(de)
|
1994-10-13 |
1996-04-18 |
Hoechst Schering Agrevo Gmbh |
Substituierte Spiroalkylamino- und alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
|
JP3993651B2
(ja)
|
1994-10-21 |
2007-10-17 |
アスビオファーマ株式会社 |
シクロプロパクロメンカルボン酸誘導体
|
US5605908A
(en)
|
1994-10-24 |
1997-02-25 |
Eli Lilly And Company |
Heterocyclic compounds and their use
|
US5821370A
(en)
|
1994-10-24 |
1998-10-13 |
Eli Lilly And Company |
Heterocyclic compounds and their preparation and use
|
US5473077A
(en)
|
1994-11-14 |
1995-12-05 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
|
US5571819A
(en)
|
1994-11-22 |
1996-11-05 |
Sabb; Annmarie L. |
Imidazopyridines as muscarinic agents
|
US5510478A
(en)
|
1994-11-30 |
1996-04-23 |
American Home Products Corporation |
2-arylamidothiazole derivatives with CNS activity
|
US5512574A
(en)
|
1994-12-21 |
1996-04-30 |
American Home Products Corporation |
Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
|
US5468875A
(en)
|
1994-12-22 |
1995-11-21 |
American Home Products Corporation |
1-azabicycloheptane derivatives
|
GB9503601D0
(en)
|
1995-02-23 |
1995-04-12 |
Merck Sharp & Dohme |
Method of treatment and method of manufacture of medicament
|
US5488055A
(en)
|
1995-03-10 |
1996-01-30 |
Sanofi Winthrop Inc. |
Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
|
HUP9801692A3
(en)
|
1995-04-21 |
2001-11-28 |
Neurosearch As |
Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
|
EP0823905A1
(en)
|
1995-05-05 |
1998-02-18 |
Novo Nordisk A/S |
Novel heterocyclic chemistry
|
DE19518082A1
(de)
|
1995-05-17 |
1996-11-21 |
Merck Patent Gmbh |
4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one
|
US5902824A
(en)
|
1995-05-18 |
1999-05-11 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phenyldihydrobenzofuranes
|
DE59610031D1
(de)
|
1995-05-18 |
2003-02-06 |
Altana Pharma Ag |
Cyclohexyldihydrobenzofurane
|
US6514996B2
(en)
|
1995-05-19 |
2003-02-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Derivatives of benzofuran or benzodioxole
|
US5637724A
(en)
|
1995-06-05 |
1997-06-10 |
Neurogen Corporation |
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
|
US5637725A
(en)
|
1995-06-05 |
1997-06-10 |
Neurogen Corporation |
Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
|
ES2235187T3
(es)
|
1995-06-06 |
2005-07-01 |
Euro-Celtique S.A. |
Esteroides neuroactivos de las series del androstano y el pregnano.
|
US5910590A
(en)
|
1995-06-07 |
1999-06-08 |
Neurogen Corporation |
Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands
|
US5534522A
(en)
|
1995-06-07 |
1996-07-09 |
Warner-Lambert Company |
(R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
|
GB9514464D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Medicaments
|
MX9800710A
(es)
|
1995-07-26 |
1998-04-30 |
Pfizer |
Derivados de n-(aroil) glicina acido hidroxamico y compuestos relacionados.
|
US20010018074A1
(en)
|
1995-07-29 |
2001-08-30 |
Smithkline Beecham P.L.C. |
Process for preparing solid dosage forms of very low-dose drugs
|
AU6514196A
(en)
|
1995-07-31 |
1997-02-26 |
Novo Nordisk A/S |
Heterocyclic compounds, their preparation and use
|
DE19533975A1
(de)
|
1995-09-14 |
1997-03-20 |
Merck Patent Gmbh |
Arylalkyl-diazinone
|
US6166041A
(en)
|
1995-10-11 |
2000-12-26 |
Euro-Celtique, S.A. |
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
|
US5800539A
(en)
|
1995-11-08 |
1998-09-01 |
Emory University |
Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease
|
ZA969485B
(en)
|
1995-11-16 |
1998-05-12 |
Lilly Co Eli |
Excitatory amino acid receptor antagonists.
|
US5688826A
(en)
|
1995-11-16 |
1997-11-18 |
Eli Lilly And Company |
Excitatory amino acid derivatives
|
US5912248A
(en)
|
1995-11-16 |
1999-06-15 |
Eli Lilly And Company |
Excitatory amino acid receptor antagonists
|
US5756501A
(en)
|
1995-12-13 |
1998-05-26 |
American Home Products Corporation |
Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
|
GB9603723D0
(en)
|
1996-02-22 |
1996-04-24 |
Merck & Co Inc |
Diphenyl pyridyl derivatives as pde iv inhibitors
|
US5710170A
(en)
|
1995-12-15 |
1998-01-20 |
Merck Frosst Canada, Inc. |
Tri-aryl ethane derivatives as PDE IV inhibitors
|
GB9526243D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526245D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526246D0
(en)
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6211365B1
(en)
|
1996-01-19 |
2001-04-03 |
Neurogen Corporation |
Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
|
US5804686A
(en)
|
1996-01-19 |
1998-09-08 |
Neurogen Corporation |
fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
|
SI0882021T1
(en)
|
1996-01-31 |
2003-10-31 |
Altana Pharma Ag |
New phenanthridines
|
GB9604926D0
(en)
|
1996-03-08 |
1996-05-08 |
Sandoz Ltd |
Organic compounds
|
US5792766A
(en)
|
1996-03-13 |
1998-08-11 |
Neurogen Corporation |
Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands
|
US5677309A
(en)
|
1996-03-22 |
1997-10-14 |
Neurogen Corporation |
1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands
|
AU2218997A
(en)
|
1996-03-22 |
1997-10-10 |
Neurogen Corporation |
Certain fused pyrrolecarboxamides as gaba brain receptor ligands
|
US6127378A
(en)
|
1996-03-26 |
2000-10-03 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phenanthridines substituted in the 6 position
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
FR2746800B1
(fr)
|
1996-03-29 |
1998-06-05 |
Jouveinal Inst Rech |
Diazepino-indoles inhibiteurs de phosphodiesterases 4
|
US6297273B1
(en)
|
1996-04-02 |
2001-10-02 |
Mars, Inc. |
Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
|
FR2754260B1
(fr)
|
1996-10-04 |
1998-10-30 |
Adir |
Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US5723462A
(en)
|
1996-04-26 |
1998-03-03 |
Neurogen Corporation |
Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
|
US20020103194A1
(en)
|
1997-04-30 |
2002-08-01 |
Anabella Villalobos |
Novel muscarinic receptor agonists
|
WO1997043287A1
(en)
|
1996-05-10 |
1997-11-20 |
Icos Corporation |
Carboline derivatives
|
US6017924A
(en)
|
1996-06-27 |
2000-01-25 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
US20020127271A1
(en)
|
1996-07-25 |
2002-09-12 |
Smithkline Beecham P.L.C. |
Formulation for the treatment and/or prophylaxis of dementia
|
SK9399A3
(en)
|
1996-07-25 |
2000-04-10 |
Merck Sharp & Dohme |
Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
|
DK0956865T4
(da)
|
1996-08-12 |
2010-11-22 |
Mitsubishi Tanabe Pharma Corp |
Medikamenter omfattende Rho-kinaseinhibitor
|
DE19632549A1
(de)
|
1996-08-13 |
1998-02-19 |
Merck Patent Gmbh |
Arylalkanoylpyridazine
|
ES2188983T4
(es)
|
1996-08-19 |
2004-06-01 |
Altana Pharma Ag |
Nuevas benzofuran-4-carboxamidas.
|
AU4205197A
(en)
|
1996-08-26 |
1998-03-19 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
New thiazole derivatives with phosphodiesterase-inhibiting effect
|
US20010003588A1
(en)
|
1996-09-12 |
2001-06-14 |
Smithkline Beecham Corporation |
Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
|
US5834458A
(en)
|
1996-10-09 |
1998-11-10 |
Eli Lilly And Company |
Heterocyclic compounds and their use
|
AU4920397A
(en)
|
1996-10-11 |
1998-05-11 |
Chiron Corporation |
Purine inhibitors of glycogen synthase kinase 3 (gsk3)
|
DE19642451A1
(de)
|
1996-10-15 |
1998-04-16 |
Merck Patent Gmbh |
Aminothiophencarbonsäureamide
|
GB9621789D0
(en)
|
1996-10-18 |
1996-12-11 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
NZ334868A
(en)
|
1996-10-21 |
2001-02-23 |
Neurosearch As |
1-Phenyl-benzimidazole compounds and their use as BAGA-a receptor modulators
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
US5773458A
(en)
|
1996-10-30 |
1998-06-30 |
American Home Products Corporation |
1-azabicycloheptane derivatives
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
US6069151A
(en)
|
1996-11-06 |
2000-05-30 |
Darwin Discovery, Ltd. |
Quinolines and their therapeutic use
|
US6043263A
(en)
|
1996-11-12 |
2000-03-28 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
(2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
|
JP2001505198A
(ja)
|
1996-11-20 |
2001-04-17 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
Pde阻害剤としての置換ジヒドロベンゾフラン
|
US6492554B2
(en)
|
2000-08-24 |
2002-12-10 |
The University Of Tennessee Research Corporation |
Selective androgen receptor modulators and methods of use thereof
|
GB9625184D0
(en)
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
JP2001508078A
(ja)
|
1997-01-15 |
2001-06-19 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
フタラジノン
|
GB9702524D0
(en)
|
1997-02-07 |
1997-03-26 |
Merck Sharp & Dohme |
Therapeutic agents
|
ATE386531T1
(de)
|
1997-02-28 |
2008-03-15 |
Nycomed Gmbh |
Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse- agonisten
|
ES2131463B1
(es)
|
1997-04-08 |
2000-03-01 |
Lilly Sa |
Derivados de ciclopropilglicina con propiedades farmaceuticas.
|
US6387673B1
(en)
|
1997-05-01 |
2002-05-14 |
The Salk Institute For Biological Studies |
Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
|
GB9708945D0
(en)
|
1997-05-01 |
1997-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6043252A
(en)
|
1997-05-05 |
2000-03-28 |
Icos Corporation |
Carboline derivatives
|
CA2288789C
(en)
|
1997-05-08 |
2009-07-21 |
Merck Sharp & Dohme Limited |
Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
|
ZA983930B
(en)
|
1997-05-14 |
1999-11-08 |
Lilly Co Eli |
Excitatory amino acid receptor modulators.
|
AU7639598A
(en)
|
1997-05-29 |
1998-12-30 |
H. Lundbeck A/S |
Treatment of schizophrenia and psychosis
|
WO1999003822A1
(en)
|
1997-07-18 |
1999-01-28 |
Georgetown University |
Bicyclic metabotropic glutamate receptor ligands
|
US6825211B1
(en)
|
1997-07-18 |
2004-11-30 |
Georgetown University |
Bicyclic metabotropic glutamate receptor ligands
|
JP2001510827A
(ja)
|
1997-07-25 |
2001-08-07 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
置換6−フェニルフェナントリジン
|
ES2137113B1
(es)
|
1997-07-29 |
2000-09-16 |
Almirall Prodesfarma Sa |
Nuevos derivados de triazolo-piridazinas heterociclicos.
|
GB9715977D0
(en)
|
1997-07-29 |
1997-10-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6107295A
(en)
|
1997-08-01 |
2000-08-22 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Arylalkanoyl pyridazines
|
CN1158281C
(zh)
|
1997-08-06 |
2004-07-21 |
第一三得利制药株式会社 |
作为iv型磷酸二酯酶抑制剂的1-芳基-1,8-二氮杂萘-4-酮衍生物
|
US6143760A
(en)
|
1997-08-25 |
2000-11-07 |
Neurogen Corporation |
Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
|
US6207842B1
(en)
|
1997-10-09 |
2001-03-27 |
Mars Incorporated |
Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
|
US6156753A
(en)
|
1997-10-28 |
2000-12-05 |
Vivus, Inc. |
Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
US6127363A
(en)
|
1997-10-28 |
2000-10-03 |
Vivus, Inc. |
Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
UA64769C2
(uk)
|
1997-11-07 |
2004-03-15 |
Х. Луннбек А/С |
Гідрогалогеніди 1'-[4-[1-(4-фторофеніл)-1н-індол-3-іл]-1-бутил]-спіро[ізобензофуран-1(3н),4'-піперидину], фармацевтична композиція та спосіб лікування
|
GB2346877B
(en)
|
1997-11-12 |
2001-12-05 |
Bayer Ag |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
|
US6429207B1
(en)
|
1997-11-21 |
2002-08-06 |
Nps Pharmaceuticals, Inc. |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
BR9815170A
(pt)
|
1997-12-12 |
2000-10-10 |
Euro Celtique S A Luxembourg |
"método de obter composto aplicável no tratamento de asma em mamìferos"
|
IT1296985B1
(it)
|
1997-12-19 |
1999-08-03 |
Zambon Spa |
Derivati benzazinici inibitori della fosfodiesterasi 4
|
US6303597B1
(en)
|
1998-01-14 |
2001-10-16 |
Merck Sharp & Dohme Limited |
Triazolo-pyridazine derivatives as ligands for GABA receptors
|
GB9801208D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9801234D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
HUP0100575A3
(en)
|
1998-01-21 |
2003-03-28 |
Merck Sharp & Dohme Ltd Hoddes |
Triazolo-pyridazine derivatives as ligands for gaba receptors
|
GB9801202D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9801210D0
(en)
|
1998-01-21 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9801397D0
(en)
|
1998-01-22 |
1998-03-18 |
Merck Sharp & Dohme |
Therapeutic agents
|
CA2285352A1
(en)
|
1998-01-29 |
1999-08-05 |
Suntory Limited |
1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase iv inhibitory activity
|
US6194427B1
(en)
|
1998-02-26 |
2001-02-27 |
Neurogen Corporation |
Substituted cycloalkyl-4-Oxonicotinic carboxamides; gaba brain receptor ligands
|
US6156898A
(en)
|
1998-02-26 |
2000-12-05 |
Neurogen Corporation |
Substituted 1,4-dihydro-4-oxonicotinic carboxamides; GABA brain receptor ligands
|
AU2879799A
(en)
|
1998-02-26 |
1999-09-15 |
Neurogen Corporation |
4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: gaba brain receptor ligands
|
AU2793199A
(en)
|
1998-02-26 |
1999-09-15 |
Neurogen Corporation |
2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives,their preparation and their use as (ant-)agonists for gaba (a) brain receptors
|
US6900228B1
(en)
|
1998-03-10 |
2005-05-31 |
Research Triangle Institute |
Opiate compounds, methods of making and methods of use
|
US6805883B2
(en)
|
1998-03-12 |
2004-10-19 |
Mars, Incorporated |
Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
|
GB9806102D0
(en)
|
1998-03-20 |
1998-05-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
FR2776660B1
(fr)
|
1998-03-27 |
2000-05-12 |
Parke Davis |
Diazepino-indoles de phosphodiesterases iv
|
US6528529B1
(en)
|
1998-03-31 |
2003-03-04 |
Acadia Pharmaceuticals Inc. |
Compounds with activity on muscarinic receptors
|
AU768990C
(en)
|
1998-04-17 |
2005-04-14 |
Prescient Neuropharma Inc. |
Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
|
JP3721077B2
(ja)
|
1998-04-20 |
2005-11-30 |
ファイザー・インク |
性的不全を治療するためのピラゾロピリミジノンcGMPPDE5阻害剤
|
ES2262072T3
(es)
|
1998-04-28 |
2006-11-16 |
Elbion Ag |
Derivados de indol y su utilizacion como inhibidores de la fosfodiesterasa 4.
|
US6897305B2
(en)
|
1998-06-08 |
2005-05-24 |
Theravance, Inc. |
Calcium channel drugs and uses
|
ATE245642T1
(de)
|
1998-06-10 |
2003-08-15 |
Altana Pharma Ag |
Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4
|
US6479506B1
(en)
|
1998-06-16 |
2002-11-12 |
Merck Sharp & Dohme Ltd. |
Triazolo-pyridine derivatives as ligands for GABA receptors
|
GB9813006D0
(en)
|
1998-06-16 |
1998-08-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
ATE274510T1
(de)
|
1998-06-19 |
2004-09-15 |
Chiron Corp |
Glycogen synthase kinase 3 inhibitoren
|
PT1095040E
(pt)
|
1998-07-06 |
2004-08-31 |
Altana Pharma Ag |
Novos benzoxazoles com actividade inibidora da pde
|
ITMI981671A1
(it)
|
1998-07-21 |
2000-01-21 |
Zambon Spa |
Derivati ftalazinici inibitori della fosfodisterasi 4
|
US6177569B1
(en)
|
1998-08-25 |
2001-01-23 |
Neurogen Corporation |
Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
|
ATE269293T1
(de)
|
1998-08-31 |
2004-07-15 |
Taisho Pharmaceutical Co Ltd |
6-fluoro(3.1.0)hexan-derivate
|
CH694053A5
(de)
|
1998-09-03 |
2004-06-30 |
Hoffmann La Roche |
Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
|
BR9913405A
(pt)
|
1998-09-03 |
2001-10-02 |
Kyowa Hakko Kogyo Kk |
Composto heterocìclico que contenha oxigênio, e, inibidor de fosfodiesterase (pde) iv.
|
WO2000015639A1
(en)
|
1998-09-16 |
2000-03-23 |
Icos Corporation |
Carboline derivatives as cgmp phosphodiesterase inhibitors
|
US6719520B2
(en)
|
1998-10-08 |
2004-04-13 |
Smithkline Beecham Corporation |
Method and compounds
|
DE69936998T2
(de)
|
1998-10-16 |
2008-05-21 |
Merck Sharp & Dohme Ltd., Hoddesdon |
Pyrazolotriazinderivate als gaba-rezeptorliganden
|
EP1129094A2
(en)
|
1998-11-12 |
2001-09-05 |
Merck & Co., Inc. |
Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
|
PE20001236A1
(es)
|
1998-11-13 |
2000-11-10 |
Lilly Co Eli |
Moduladores del receptor de aminoacidos excitadores
|
SE9804064D0
(sv)
|
1998-11-25 |
1998-11-25 |
A & Science Invest Ab |
Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
|
US6130333A
(en)
|
1998-11-27 |
2000-10-10 |
Monsanto Company |
Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
|
US6414147B1
(en)
|
1998-12-23 |
2002-07-02 |
Neurogen Corporation |
2-amino-9-alkylpurines: GABA brain receptor ligands
|
AU772947B2
(en)
|
1999-01-27 |
2004-05-13 |
Merck Sharp & Dohme Limited |
Triazolo-pyridazine derivatives as ligands for GABA receptors
|
US6342496B1
(en)
|
1999-03-01 |
2002-01-29 |
Sepracor Inc. |
Bupropion metabolites and methods of use
|
US6498176B1
(en)
|
1999-03-04 |
2002-12-24 |
Smithklinebeecham Corporation |
3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
|
TW575561B
(en)
|
1999-03-25 |
2004-02-11 |
Hoffmann La Roche |
1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
|
ATE298343T1
(de)
|
1999-04-28 |
2005-07-15 |
Univ Georgetown |
Ligande für metabotropische glutamat-rezeptoren
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
FR2792938B1
(fr)
|
1999-04-28 |
2001-07-06 |
Warner Lambert Co |
NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
|
US6943166B1
(en)
|
1999-04-30 |
2005-09-13 |
Lilly Icos Llc. |
Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
|
US6316472B1
(en)
|
1999-05-13 |
2001-11-13 |
Merck Frosst Canada & Co. |
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
|
WO2000071528A1
(en)
|
1999-05-25 |
2000-11-30 |
Neurogen Corporation |
4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
|
WO2000075101A1
(en)
|
1999-06-03 |
2000-12-14 |
Lilly, S.A. |
Excitatory amino acid receptor modulators
|
CA2376432A1
(en)
|
1999-06-10 |
2000-12-21 |
Takeda Chemical Industries, Ltd. |
Novel protein and dna thereof
|
US6146876A
(en)
|
1999-06-11 |
2000-11-14 |
Millennium Pharmaceuticals, Inc. |
22025, a novel human cyclic nucleotide phosphodiesterase
|
US6297256B1
(en)
|
1999-06-15 |
2001-10-02 |
Neurogen Corporation |
Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands
|
DE19928146A1
(de)
|
1999-06-19 |
2000-12-21 |
Merck Patent Gmbh |
Thienopyrimidine
|
KR20020020788A
(ko)
|
1999-07-21 |
2002-03-15 |
후지야마 아키라 |
벤즈이미다졸론 유도체 및 포스포디에스테라제억제제로서의 이의 용도
|
US6821975B1
(en)
|
1999-08-03 |
2004-11-23 |
Lilly Icos Llc |
Beta-carboline drug products
|
DE60006618T2
(de)
|
1999-08-06 |
2004-09-23 |
F. Hoffmann-La Roche Ag |
Tetrahydro-benzo(d)azepine und deren Verwendung als metabotrope Glutamatrezeptor-Antagonisten
|
WO2001012630A1
(en)
|
1999-08-13 |
2001-02-22 |
Sepracor Inc. |
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
US6313159B1
(en)
|
1999-08-20 |
2001-11-06 |
Guilford Pharmaceuticals Inc. |
Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
|
GB9919957D0
(en)
|
1999-08-23 |
1999-10-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
US20050014939A1
(en)
|
1999-08-31 |
2005-01-20 |
Neurogen Corporation |
Fused pyrrolecarboxamides: GABA brain receptor ligands
|
US6956049B1
(en)
|
1999-08-31 |
2005-10-18 |
Merck & Co., Inc. |
Methods of modulating processes mediated by excitatory amino acid receptors
|
GB9921150D0
(en)
|
1999-09-07 |
1999-11-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9921351D0
(en)
|
1999-09-09 |
1999-11-10 |
Merck Sharp & Dohme |
Therapeutic agents
|
TWI265925B
(en)
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
US6552016B1
(en)
|
1999-10-14 |
2003-04-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
NZ518037A
(en)
|
1999-10-15 |
2004-04-30 |
F |
Benzodiazepine derivatives useful as metabotropic glutamate receptors
|
US7491742B2
(en)
|
1999-10-21 |
2009-02-17 |
Merck Patent Gmbh |
Imidazole derivatives as phosphodiesterase VII inhibitors
|
US6534287B1
(en)
|
1999-10-25 |
2003-03-18 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
AR029185A1
(es)
|
1999-10-25 |
2003-06-18 |
Yamanouchi Pharma Co Ltd |
Derivado de naftiridina
|
DE19953025A1
(de)
|
1999-11-04 |
2001-05-10 |
Merck Patent Gmbh |
Pyrrolderivate als Phosphodiesterase VII-Hemmer
|
DE19953414A1
(de)
|
1999-11-06 |
2001-05-10 |
Merck Patent Gmbh |
Imidazopyridinderivate als Phospodiesterase VII-Hemmer
|
DE19954707A1
(de)
|
1999-11-13 |
2001-05-17 |
Merck Patent Gmbh |
Imidazolverbindungen als Phosphodiesterase VII-Hemmer
|
KR20020070285A
(ko)
|
1999-11-23 |
2002-09-05 |
메틸진, 인크. |
히스톤 디아세틸라제의 억제제
|
GB9927687D0
(en)
|
1999-11-23 |
2000-01-19 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE60008917T2
(de)
|
1999-12-08 |
2005-03-10 |
Grelan Pharmaceutical Co., Ltd., Hamura |
Neue 1,8-naphtyridin-2(1h)-on-derivate
|
ES2213996T3
(es)
|
1999-12-08 |
2004-09-01 |
Centre National De La Recherche Scientifique (Cnrs) |
Uso de himenialdisina o sus derivados en la fabricacion de medicamentos.
|
GB9929685D0
(en)
|
1999-12-15 |
2000-02-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9929687D0
(en)
|
1999-12-15 |
2000-02-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6376489B1
(en)
|
1999-12-23 |
2002-04-23 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6680336B2
(en)
|
1999-12-15 |
2004-01-20 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
EP1240168B1
(en)
|
1999-12-17 |
2005-08-31 |
Chiron Corporation |
Bicyclic inhibitors of glycogen synthase kinase 3
|
US6372777B1
(en)
|
1999-12-23 |
2002-04-16 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6362213B1
(en)
|
1999-12-23 |
2002-03-26 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6258833B1
(en)
|
1999-12-23 |
2001-07-10 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6294561B1
(en)
|
1999-12-23 |
2001-09-25 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6313156B1
(en)
|
1999-12-23 |
2001-11-06 |
Icos Corporation |
Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
|
US6569885B1
(en)
|
1999-12-23 |
2003-05-27 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6348602B1
(en)
|
1999-12-23 |
2002-02-19 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
GB0000564D0
(en)
|
2000-01-11 |
2000-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
IL150486A0
(en)
|
2000-01-31 |
2002-12-01 |
Pfizer Prod Inc |
Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
|
CA2398255A1
(en)
|
2000-02-01 |
2001-08-09 |
Human Genome Sciences, Inc. |
Bcl-2-like polynucleotides, polypeptides, and antibodies
|
US6800651B2
(en)
|
2000-02-03 |
2004-10-05 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
US20010039275A1
(en)
|
2000-02-04 |
2001-11-08 |
Bowler Andrew Neil |
Use of 2,4-diaminothiazole derivatives
|
US20010034373A1
(en)
*
|
2000-02-09 |
2001-10-25 |
Matthew Miller |
Low dose modafinil for enhancement of cognitive function
|
GB0003254D0
(en)
|
2000-02-11 |
2000-04-05 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
FR2804959B1
(fr)
|
2000-02-15 |
2006-04-28 |
Centre Nat Rech Scient |
Utilisation de derives de paullones pour la fabrication de medicaments
|
CN100384836C
(zh)
|
2000-02-29 |
2008-04-30 |
三菱制药株式会社 |
新型环状酰胺衍生物
|
GB0005700D0
(en)
|
2000-03-09 |
2000-05-03 |
Glaxo Group Ltd |
Therapy
|
IL151838A0
(en)
|
2000-03-20 |
2003-04-10 |
Teva Pharma |
Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n- (4-methoxyphenyl)-3-chloropropionamide
|
CA2404226A1
(en)
|
2000-03-23 |
2001-09-27 |
Takeda Chemical Industries, Ltd. |
Furoisoquinoline derivatives, process for producing the same and use thereof
|
EP1280764B1
(en)
|
2000-03-24 |
2010-11-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
GB0007193D0
(en)
|
2000-03-25 |
2000-05-17 |
Univ Manchester |
Treatment of movrmrnt disorders
|
GB0008696D0
(en)
|
2000-04-07 |
2000-05-31 |
Merck Sharp & Dohme |
Therapeutic agents
|
ATE439051T1
(de)
|
2000-04-14 |
2009-08-15 |
Mars Inc |
Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
|
CA2306170A1
(en)
|
2000-04-18 |
2001-10-18 |
Kenneth Curry |
Novel amino, carboxy derivatives of barbituric acid
|
CN1249051C
(zh)
|
2000-04-28 |
2006-04-05 |
阿卡蒂亚药品公司 |
毒蕈碱性激动剂
|
RU2294931C2
(ru)
|
2000-05-11 |
2007-03-10 |
Консехо Супериор Инвестигасионес Сьентификас |
Гетероциклические ингибиторы гликоген-синтазы киназы gsk-3
|
ATE265419T1
(de)
|
2000-05-11 |
2004-05-15 |
Kenneth Curry |
Spiro(2.4)heptanaminocarbonsäure und ihre derivate
|
UA72611C2
(uk)
|
2000-05-17 |
2005-03-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази
|
UA74826C2
(en)
|
2000-05-17 |
2006-02-15 |
Ortho Mcneil Pharm Inc |
?-carboline derivatives as phosphodiesterase inhibitors
|
WO2001090108A1
(en)
|
2000-05-24 |
2001-11-29 |
Merck Sharp & Dohme Limited |
3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
|
DK1289383T3
(da)
|
2000-05-30 |
2006-08-14 |
Nestle Sa |
Grundsammensætning indeholdende en lipofil bioaktiv forbindelse
|
US7081481B2
(en)
|
2000-05-31 |
2006-07-25 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
EP1286997B1
(en)
|
2000-06-07 |
2004-08-18 |
Almirall Prodesfarma, S.A. |
6-phenylpyrrolopyrimidinedione derivatives
|
ES2269408T3
(es)
|
2000-06-23 |
2007-04-01 |
Lilly Icos Llc |
Inhibidores de fosfodiesterasa especifica de gmp ciclico.
|
US6589978B2
(en)
|
2000-06-30 |
2003-07-08 |
Hoffman-La Roche Inc. |
1-sulfonyl pyrrolidine derivatives
|
US6399641B1
(en)
|
2000-07-13 |
2002-06-04 |
Hoffmann-La Roche Inc. |
2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
|
GB0018473D0
(en)
|
2000-07-27 |
2000-09-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
ES2233685T3
(es)
|
2000-08-01 |
2005-06-16 |
Bayer Healthcare Ag |
Inhibidores selectivos de pde 2 como medicamentos para mejorar la percepcion.
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
WO2002022579A2
(en)
|
2000-09-11 |
2002-03-21 |
Sepracor, Inc. |
Antipsychotic sulfonamide-heterocycles, and methods of use thereof
|
DE60120193T2
(de)
|
2000-09-15 |
2007-03-29 |
Vertex Pharmaceuticals Inc., Cambridge |
Pyrazolverbindungen als protein-kinasehemmer
|
US6613776B2
(en)
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6610677B2
(en)
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
EP1328510B1
(en)
|
2000-09-29 |
2013-11-20 |
TopoTarget UK Limited |
(e)-n-hydroxy-3-(3-sulfamoyl-phenyl)-acrylamide compounds and their therapeutic use
|
EP1335898B1
(en)
|
2000-09-29 |
2005-11-23 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
EP1193261A1
(en)
|
2000-10-02 |
2002-04-03 |
Warner-Lambert Company |
New thiadiazoles and their use as phosphodiesterase-7 inhibitors
|
MXPA03002907A
(es)
|
2000-10-02 |
2003-06-24 |
Janssen Pharmaceutica Nv |
Antagonistas receptores metabotropicos de glutamato.
|
US20020103192A1
(en)
|
2000-10-26 |
2002-08-01 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
GB0117277D0
(en)
|
2001-07-16 |
2001-09-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0027561D0
(en)
|
2000-11-10 |
2000-12-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6936608B2
(en)
|
2000-11-10 |
2005-08-30 |
Merck Sharp & Dohme Ltd. |
Imidazo-triazine derivatives as ligands for GABA receptors
|
US6818651B2
(en)
|
2000-11-14 |
2004-11-16 |
Altana Pharma Ag |
(Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors
|
AR035659A1
(es)
|
2000-12-07 |
2004-06-23 |
Hoffmann La Roche |
Hidroxiamidas de acido (1-oxo-1,2,3,4-tetrahidro-naftalen-2-il)-alcanoico, proceso para la manufactura de estos compuestos, composiciones farmaceuticas que contienen dichos compuestos y los usos de los mismos
|
JP2004517843A
(ja)
|
2000-12-13 |
2004-06-17 |
バイエル アクチェンゲゼルシャフト |
ピロロ[2.1−a]ジヒドロイソキノリンおよびホスホジエステラーゼ10a阻害薬としてのその使用
|
US6900215B2
(en)
|
2000-12-15 |
2005-05-31 |
Merck Sharp & Dohme Ltd. |
Imidazo-pyrimidine derivatives as ligands for gaba receptors
|
US6562995B1
(en)
|
2000-12-21 |
2003-05-13 |
Beacon Laboratories, Inc. |
Delta dicarbonyl compounds and methods for using the same
|
ATE528303T1
(de)
|
2000-12-21 |
2011-10-15 |
Vertex Pharma |
Pyrazoleverbindungen als proteinkinasehemmer
|
US6720445B2
(en)
|
2000-12-21 |
2004-04-13 |
Beacon Laboratories, Inc. |
Acetyloxymethyl esters and methods for using the same
|
MXPA03005515A
(es)
|
2000-12-22 |
2003-09-25 |
Hoffmann La Roche |
Derivados de tetrahidro-(benzo o tieno)-azepina-pirazina y triazina como antagonistas de mglur 1.
|
AR035513A1
(es)
|
2000-12-23 |
2004-06-02 |
Hoffmann La Roche |
Derivados de tetrahidropiridina, proceso para prepararlos, composiciones farmaceuticas que los contienen, y uso de dichos compuestos en la preparacion de medicamentos
|
GR1003861B
(el)
|
2000-12-29 |
2002-04-11 |
|
Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
|
US6974824B2
(en)
|
2001-01-08 |
2005-12-13 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
AR035417A1
(es)
|
2001-01-27 |
2004-05-26 |
Hoffmann La Roche |
Derivados triciclicos de lactama y sultama, procesos para su elaboracion, medicamentos que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
|
PL364910A1
(en)
|
2001-01-31 |
2004-12-27 |
Pfizer Products Inc. |
Ether derivatives useful as inhibitors of pde4 isozymes
|
JP2004520386A
(ja)
|
2001-01-31 |
2004-07-08 |
ファイザー・プロダクツ・インク |
Pde4アイソザイムの阻害剤として有用なニコチンアミドビアリール誘導体
|
HUP0401305A2
(hu)
|
2001-01-31 |
2004-10-28 |
Pfizer Products Inc. |
Tiazolil-, oxazolil-, pirrolil- és imidazolil-savamid-származékok, mint PDE4 izozimek inhibitorai és az ezeket tartalmazó gyógyszerkészítmények
|
US6559159B2
(en)
|
2001-02-01 |
2003-05-06 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
US6617357B2
(en)
|
2001-03-06 |
2003-09-09 |
Smithkline Beecham Corporation |
Compounds and their use as PDE inhibitors
|
US20020177594A1
(en)
|
2001-03-14 |
2002-11-28 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
AP1699A
(en)
|
2001-03-21 |
2006-12-26 |
Warner Lambert Co |
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
KR100909923B1
(ko)
|
2001-04-19 |
2009-07-29 |
미쓰비시 타나베 파마 코퍼레이션 |
N-(2,3-디메틸-5,6,7,8-테트라히드로푸로[2,3-b]퀴놀린-4-일)-2-(2-옥소피롤리딘-1-일)아세트아미드의 다형체
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
GB0111191D0
(en)
|
2001-05-08 |
2001-06-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
US20030187027A1
(en)
|
2001-05-09 |
2003-10-02 |
Schreiber Stuart L. |
Dioxanes and uses thereof
|
US6762179B2
(en)
|
2001-05-31 |
2004-07-13 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinase
|
JP2004537531A
(ja)
|
2001-06-12 |
2004-12-16 |
エスケー コーポレイション |
新規フェニルアルキルジアミンおよびアミド類似体
|
JP2005500294A
(ja)
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ7に対するピリミジン阻害剤
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
DE10130167A1
(de)
|
2001-06-22 |
2003-01-02 |
Bayer Ag |
Imidazotriazine
|
GB0117060D0
(en)
|
2001-07-12 |
2001-09-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
CA2456594A1
(en)
|
2001-08-06 |
2003-02-20 |
Mitsubishi Pharma Corporation |
Preventives/remedies for cholinergic neuropathy
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
JO2311B1
(en)
|
2001-08-29 |
2005-09-12 |
ميرك فروست كندا ليمتد |
Alkyl inhibitors Ariel phosphodiesterase-4
|
US6897220B2
(en)
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
MXPA04002397A
(es)
|
2001-09-14 |
2004-12-02 |
Methylgene Inc |
Inhibidores de histona deacetilasa.
|
EP1295885A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
|
EP1295884A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives
|
JP2005504807A
(ja)
|
2001-09-26 |
2005-02-17 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
抗糖尿病薬としての1,8−ナフチリジン誘導体
|
EP1432420B1
(en)
|
2001-10-02 |
2011-07-13 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
US6951849B2
(en)
|
2001-10-02 |
2005-10-04 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
US6924311B2
(en)
|
2001-10-17 |
2005-08-02 |
X-Ceptor Therapeutics, Inc. |
Methods for affecting various diseases utilizing LXR compounds
|
AU2002337956B2
(en)
|
2001-10-25 |
2006-02-23 |
Schering Corporation |
MCH Antagonists for the treatment of obesity
|
AU2002363176B2
(en)
|
2001-11-01 |
2008-09-25 |
Janssen Pharmaceutica N.V. |
Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)
|
ATE375331T1
(de)
|
2001-11-01 |
2007-10-15 |
Janssen Pharmaceutica Nv |
Amidderivate als inhibitoren der glycogensynthasekinase-3-beta
|
EP1448562B1
(en)
|
2001-11-14 |
2007-07-25 |
Ortho-Mcneil Pharmaceutical Corp. |
Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
AU2002365892A1
(en)
|
2001-11-30 |
2003-06-17 |
Merck & Co., Inc. |
Metabotropic glutamate receptor-5 modulators
|
WO2003053975A1
(fr)
|
2001-12-13 |
2003-07-03 |
Daiichi Suntory Pharma Co., Ltd. |
Derives de pyrazolopyrimidinone possedant une activite inhibitrice de pde7
|
ES2295441T3
(es)
|
2001-12-18 |
2008-04-16 |
MERCK & CO., INC. |
Moduladores de pirazol heteroaril sustituido de receptor 5 metabotropico de glutamato.
|
US7105548B2
(en)
|
2001-12-18 |
2006-09-12 |
Merck & Co., Inc. |
Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
|
AU2002360621B2
(en)
|
2001-12-19 |
2007-01-25 |
Merck & Co., Inc. |
heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
|
CA2470519C
(en)
|
2001-12-21 |
2009-11-17 |
Merck & Co., Inc. |
Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
|
DE10163991A1
(de)
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
Pyrrolo-pyrimidine
|
CA2366325A1
(en)
|
2001-12-27 |
2003-06-27 |
Todd Howley |
Method of forming turbine blade root
|
NZ533699A
(en)
|
2001-12-27 |
2006-05-26 |
Taisho Pharmaceutical Co Ltd |
6-fluorobicyclo[3.1.0]hexane derivatives
|
US7550459B2
(en)
|
2001-12-28 |
2009-06-23 |
Acadia Pharmaceuticals, Inc. |
Tetrahydroquinoline analogues as muscarinic agonists
|
IL162616A0
(en)
|
2001-12-28 |
2005-11-20 |
Acadia Pharm Inc |
Tetrahydroquinoline analogues as muscarinic agonists
|
NZ533567A
(en)
|
2001-12-28 |
2007-06-29 |
Acadia Pharm Inc |
Spiroazacyclic compounds as monoamine receptor for modulating 5-HT2A receptor-mediated events
|
US6495700B1
(en)
|
2002-01-09 |
2002-12-17 |
Axonyx, Inc. |
Process for producing phenserine and its analog
|
JPWO2003061658A1
(ja)
|
2002-01-22 |
2005-05-19 |
エーザイ株式会社 |
インダノン誘導体を含有するシグマ受容体結合剤
|
TW200302726A
(en)
|
2002-01-31 |
2003-08-16 |
Ono Pharmaceutical Co |
Nitrogen-containing bicyclic compound and medicament containing same as active ingredient
|
PL372756A1
(en)
|
2002-02-11 |
2005-08-08 |
Pfizer Inc. |
Nicotinamide derivatives useful as pde4 inhibitors
|
EP1477490A4
(en)
|
2002-02-22 |
2006-03-08 |
Teijin Ltd |
PYRROLOPYRIMIDINE DERIVATIVE
|
ATE486600T1
(de)
|
2002-03-12 |
2010-11-15 |
Merck Sharp & Dohme |
Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5
|
EA007272B1
(ru)
|
2002-03-13 |
2006-08-25 |
Янссен Фармацевтика Н. В. |
Новые ингибиторы гистондеацетилазы
|
MXPA04007776A
(es)
|
2002-03-13 |
2004-10-15 |
Janssen Pharmaceutica Nv |
Derivados de sulfonilamino como nuevos inhibidores de histona deacetilasa.
|
BR0307606A
(pt)
|
2002-03-13 |
2004-12-21 |
Janssen Pharmaceutica Nv |
Derivados de piperazinila, piperidinila e morfolinila como inibidores de histona desacetilase
|
NZ534830A
(en)
|
2002-03-13 |
2005-08-26 |
Janssen Pharmaceutica Nv |
Compounds with histone deacetylase HDAC inhibiting activity and oral bioavailability useful for treating proliferative diseases
|
ES2284739T3
(es)
|
2002-03-20 |
2007-11-16 |
Societe Des Produits Nestle S.A. |
Extracto de cacao con bajo contenido en grasa.
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
ATE399012T1
(de)
|
2002-04-03 |
2008-07-15 |
Topotarget Uk Ltd |
Carbaminsäurederivate enthaltend eine piperazin verknüpfung als hdac-inhibitoren
|
GB0210124D0
(en)
|
2002-05-02 |
2002-06-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0212048D0
(en)
|
2002-05-24 |
2002-07-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE60317684D1
(de)
|
2002-06-19 |
2008-01-03 |
Janssen Pharmaceutica Nv |
SUBSTITUIERTE 2,4-DIHYDROPYRROLOc3,4BÜCHINOLIN-9-ONDERIVATE, DIE SICH ALS PHOSPHODIESTERASEINHIBITOREN EIGNEN
|
US7405230B2
(en)
|
2002-07-19 |
2008-07-29 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
|
EP1400244A1
(en)
|
2002-09-17 |
2004-03-24 |
Warner-Lambert Company LLC |
New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
|
CA2500587A1
(en)
|
2002-10-04 |
2004-04-22 |
The Regents Of The University Of California |
Screening and therapeutic methods relating to neurogenesis
|
AU2003282976A1
(en)
|
2002-10-21 |
2004-05-13 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
WO2004045592A2
(en)
|
2002-11-20 |
2004-06-03 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
ES2209650B2
(es)
|
2002-12-09 |
2006-11-01 |
Laboratorios Del Dr. Esteve, S.A. |
Mamiferos no humanos mutantes deficientes en receptores sigma y sus aplicaciones.
|
US20040185429A1
(en)
|
2002-12-09 |
2004-09-23 |
Judith Kelleher-Andersson |
Method for discovering neurogenic agents
|
EP1598355A4
(en)
*
|
2003-01-08 |
2010-01-27 |
Mitsubishi Tanabe Pharma Corp |
THERAPEUTIC AGENT FOR SCHIZOPHRENIA
|
TW200418806A
(en)
|
2003-01-13 |
2004-10-01 |
Fujisawa Pharmaceutical Co |
HDAC inhibitor
|
BRPI0406810A
(pt)
|
2003-01-31 |
2005-12-27 |
Astrazeneca Ab |
Compostos, processos de preparação e uso respectivos, composição farmacêutica e métodos de inibição da ativação dos receptores de mglur do grupo i e de tratamento de desordens mediadas pelos mesmos
|
US6969716B2
(en)
|
2003-02-07 |
2005-11-29 |
Merck Sharp & Dohme Ltd. |
5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression
|
US7407962B2
(en)
|
2003-02-07 |
2008-08-05 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl compounds useful as inhibitors or protein kinases
|
TWI292318B
(en)
|
2003-03-10 |
2008-01-11 |
Hoffmann La Roche |
Imidazol-4-yl-ethynyl-pyridine derivatives
|
EP1608628A2
(en)
|
2003-03-17 |
2005-12-28 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
JP2006521399A
(ja)
|
2003-03-28 |
2006-09-21 |
アカディア ファーマシューティカルズ,インコーポレーテッド |
疼痛管理用ムスカリンm1受容体アゴニスト
|
AU2004227945B2
(en)
|
2003-04-04 |
2006-10-26 |
Dynogen Pharmaceuticals, Inc. |
Method of treating lower urinary tract disorders
|
BRPI0410235A
(pt)
|
2003-04-16 |
2006-05-09 |
Memory Pharm Corp |
inibição de pde4, composto, composição farmacêutica, método para efetuar a inibição da enzima pde4, incrementar a cognição e/ou tratar a psicose em um paciente, método para o tratamento de um paciente que tem uma doença que envolve nìveis de camp diminuìdos, método para o tratamento de um paciente que sofre de uma doença alérgica ou inflamatória e método para o tratamento de um paciente que sofre de neurodegeneração resultante de uma doença ou de um ferimento
|
US20040254152A1
(en)
|
2003-04-17 |
2004-12-16 |
Monje Michelle L. |
Prevention of deficits in neurogenesis with anti-inflammatory agents
|
GB0311859D0
(en)
|
2003-05-22 |
2003-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
US7763588B2
(en)
|
2003-06-13 |
2010-07-27 |
The Salk Institute For Biological Studies |
Method for increasing cognitive function and neurogenesis
|
US7842835B2
(en)
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
EP1651234B1
(en)
|
2003-07-25 |
2007-09-26 |
F. Hoffmann-La Roche Ag |
Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders
|
WO2005017189A2
(en)
|
2003-08-05 |
2005-02-24 |
University Of Florida Research Foundation, Inc. |
Neural cell assay
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
CA2541548A1
(en)
|
2003-10-10 |
2005-04-21 |
Mars, Incorporated |
Treatment of diseases involving erbb2 kinase overexpression
|
PT1541197E
(pt)
|
2003-12-02 |
2009-06-04 |
Pharmaneuroboost N V |
Utilização de pipamperona e de um sndri, snri ou ssri para o tratamento de patologias do temperamento ou da ansiedade
|
US20050159470A1
(en)
|
2003-12-19 |
2005-07-21 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
WO2005066151A2
(en)
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
SG133606A1
(en)
|
2003-12-22 |
2007-07-30 |
Acadia Pharm Inc |
Amino substituted diaryl [a,d] cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
|
EP1718280A4
(en)
|
2004-01-30 |
2010-08-18 |
Mars Inc |
METHOD AND COMPOSITIONS FOR CANCER TREATMENT
|
TWI301760B
(en)
|
2004-02-27 |
2008-10-11 |
Merz Pharma Gmbh & Co Kgaa |
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
|
EP2317316A3
(en)
|
2005-07-08 |
2011-06-15 |
Braincells, Inc. |
Methods for identifying agent and conditions that modulate neurogenesis
|
JP2009525979A
(ja)
*
|
2006-02-07 |
2009-07-16 |
田辺三菱製薬株式会社 |
4−アシルアミノピリジン誘導体を介した神経新生
|